{"id":1068206,"date":"2022-04-01T02:09:07","date_gmt":"2022-04-01T06:09:07","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/biosyent-announces-grant-of-restricted-share-units\/"},"modified":"2024-08-18T11:44:18","modified_gmt":"2024-08-18T15:44:18","slug":"biosyent-announces-grant-of-restricted-share-units","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/biosyent-announces-grant-of-restricted-share-units.php","title":{"rendered":"BioSyent Announces Grant of Restricted Share Units"},"content":{"rendered":"<p><![CDATA[MISSISSAUGA, Ontario, March  31, 2022  (GLOBE NEWSWIRE) -- BioSyent Inc. (\u201cBioSyent\u201d or the \u201cCompany\u201d, TSX Venture: RX) announces that its Board of Directors has approved a grant of 56,957 Restricted Share Units \u201cRSUs\u201d to certain directors, officers, management, and employees of the Company pursuant to the Company\u2019s Restricted Share Unit Plan (the \u201cRSU Plan\u201d). These RSUs will fully vest within three years on the third anniversary of the applicable grant date.]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/03\/31\/2414418\/0\/en\/BioSyent-Announces-Grant-of-Restricted-Share-Units.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"BioSyent Announces Grant of Restricted Share Units\">BioSyent Announces Grant of Restricted Share Units<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: BioSyent Announces Grant of Restricted Share Units <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/biosyent-announces-grant-of-restricted-share-units.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068206","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068206"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068206"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068206\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}